• About ExonHit
  • Diagnostics
  • Therapeutics
  • Technology
  • Investors
  • News Center
  •  
  •  

ExonHit is a fast emerging healthcare player active in both therapeutics and diagnostics. ExonHit is based in Paris, France, and has US offices in Gaithersburg, Maryland. The Company employs 65 associates.

Home

Navigation

  • About ExonHit
    • Overview
    • History
    • Management Board
      • Loïc Maurel M.D.
      • Hervé Duchesne de Lamotte
      • Matthew Pando Ph.D
    • Supervisory Board
      • Laurent Condomine
      • Patrick Langlois
      • Christophe Jean
      • Deborah Smeltzer
      • Frederic Desdouits
      • Michel Picot
    • Scientific Advisory Board
      • Pierre Chambon
      • Dominique Stehelin
      • Edwin Milgrom
      • Gustavo C. Roman
      • Pascale Briand
      • Pierre Corvol
    • Join Us
    • Locations

Languages

  • English
  • Français

Print

  • CLICK HERE TO PRINT

Contact us

Send this article
 


 
Home » About ExonHit » Supervisory Board
 » Christophe Jean
Christophe Jean
< Back
Christophe Jean

Board Member

French

Christophe worked for Ciba Geigy AG and Novartis Pharma AG before becoming Chief Executive Officer of Pierre Fabre Medicament in 2000. He has been Executive Vice President of Ipsen since 2003, in charge of world-wide operations and strategic planning. Christophe has also been a Director of Tercica since 2007.

Christophe has an MBA from Harvard University.

Site map - © 2009 ExonHit Therapeutics. All Rights Reserved - Legal information -